Oxford Biomedica plc (LON:OXB)
London flag London · Delayed Price · Currency is GBP · Price in GBX
598.00
-3.00 (-0.50%)
Apr 29, 2026, 12:14 PM GMT

Oxford Biomedica Balance Sheet

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
96.8860.65103.72141.29108.94
Upgrade
Trading Asset Securities
0.02---0.07
Upgrade
Cash & Short-Term Investments
96.960.65103.72141.29109.02
Upgrade
Cash Growth
59.77%-41.52%-26.59%29.60%132.04%
Upgrade
Accounts Receivable
47.8841.3313.3445.0135.95
Upgrade
Other Receivables
17.313.77.0412.616.15
Upgrade
Receivables
65.1855.0320.3957.6242.1
Upgrade
Inventory
17.3313.5712.8712.639.52
Upgrade
Prepaid Expenses
6.093.944.363.983.21
Upgrade
Other Current Assets
0.15----
Upgrade
Total Current Assets
185.65133.19141.33215.5163.84
Upgrade
Property, Plant & Equipment
107.6364.375.69133.7869.73
Upgrade
Goodwill
---0.66-
Upgrade
Other Intangible Assets
25.1729.2230.98105.230.05
Upgrade
Long-Term Accounts Receivable
-0.030.04--
Upgrade
Other Long-Term Assets
7.284.94.35.013.61
Upgrade
Total Assets
325.72231.64252.34460.18237.23
Upgrade
Accounts Payable
14.219.616.0513.65.26
Upgrade
Accrued Expenses
18.9715.0410.2720.6311.9
Upgrade
Current Portion of Long-Term Debt
-0.28---
Upgrade
Current Portion of Leases
6.064.143.653.30.85
Upgrade
Current Income Taxes Payable
2.181.511.482.351.9
Upgrade
Current Unearned Revenue
42.824.1922.1119.2613.4
Upgrade
Other Current Liabilities
-3.540.75--
Upgrade
Total Current Liabilities
84.2258.3244.3259.6633.31
Upgrade
Long-Term Debt
41.4939.7938.5339.78-
Upgrade
Long-Term Leases
100.5864.5569.2771.218.49
Upgrade
Long-Term Unearned Revenue
0.691.075.331.151.85
Upgrade
Long-Term Deferred Tax Liabilities
---5.59-
Upgrade
Other Long-Term Liabilities
7.397.4217.0646.616.24
Upgrade
Total Liabilities
234.37171.16174.51223.9949.89
Upgrade
Common Stock
60.3852.9848.448.1343.09
Upgrade
Additional Paid-In Capital
445.85394.86380.33379.95307.77
Upgrade
Retained Earnings
-422.35-399.5-352.92-198.55-165.81
Upgrade
Comprehensive Income & Other
7.478.71-1.81-24.892.29
Upgrade
Total Common Equity
91.3557.0574.01204.65187.34
Upgrade
Minority Interest
-3.443.8331.54-
Upgrade
Shareholders' Equity
91.3560.4977.83236.19187.34
Upgrade
Total Liabilities & Equity
325.72231.64252.34460.18237.23
Upgrade
Total Debt
148.13108.76111.46114.289.34
Upgrade
Net Cash (Debt)
-51.23-48.11-7.742799.68
Upgrade
Net Cash Growth
----72.91%200.80%
Upgrade
Net Cash Per Share
-0.46-0.47-0.080.281.16
Upgrade
Filing Date Shares Outstanding
120.75105.9696.896.2686.18
Upgrade
Total Common Shares Outstanding
120.75105.9696.896.2686.18
Upgrade
Working Capital
101.4374.8797.01155.84130.54
Upgrade
Book Value Per Share
0.760.540.762.132.17
Upgrade
Tangible Book Value
66.1827.8343.0398.77187.29
Upgrade
Tangible Book Value Per Share
0.550.260.441.032.17
Upgrade
Machinery
86.3170.865.3361.0240.17
Upgrade
Leasehold Improvements
60.6161.2961.0660.2328.15
Upgrade
Order Backlog
2041509494-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.